| Product NDC: | 0173-0424 |
| Proprietary Name: | ZINACEF |
| Non Proprietary Name: | cefuroxime |
| Active Ingredient(s): | 750 mg/50mL & nbsp; cefuroxime |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0173-0424 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050643 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19890501 |
| Package NDC: | 0173-0424-00 |
| Package Description: | 24 CONTAINER in 1 CARTON (0173-0424-00) > 50 mL in 1 CONTAINER |
| NDC Code | 0173-0424-00 |
| Proprietary Name | ZINACEF |
| Package Description | 24 CONTAINER in 1 CARTON (0173-0424-00) > 50 mL in 1 CONTAINER |
| Product NDC | 0173-0424 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cefuroxime |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19890501 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | CEFUROXIME SODIUM |
| Strength Number | 750 |
| Strength Unit | mg/50mL |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |